Kestra Advisory Services’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-11,852
| Closed | -$295K | – | 2938 |
|
|
2025
Q1 | $295K | Sell |
11,852
-4,044
| -25% | -$100K | ﹤0.01% | 2180 |
|
|
2024
Q4 | $299K | Buy |
+15,896
| New | +$299K | ﹤0.01% | 2209 |
|
|
2021
Q2 | – | Sell |
-3,672
| Closed | -$257K | – | 2026 |
|
|
2021
Q1 | $257K | Buy |
3,672
+111
| +3% | +$7.77K | ﹤0.01% | 1563 |
|
|
2020
Q4 | $209K | Buy |
+3,561
| New | +$209K | ﹤0.01% | 1693 |
|